Skip to main content

Table 4 The predictors for eGFR improvement 1 year after offtreatment with LdT and ETV compared with baseline

From: Comparison of telbivudine and entecavir on the change of off- treatment eGFR after 3 years of treatment in non-cirrhotic chronic hepatitis B patients

 

Univariate logistic regression

Multivariate logistic regression

 

OR

95%CI

P-value

OR

95%CI

P-value

Age

1.03

0.99–1.07

0.10

1.03

0.98–1.08

0.20

Sex

0.50

0.16–1.51

0.22

0.86

0.23–3.19

0.82

LdT

3.02

1.22–7.51

0.02

3.97

1.37–11.5

0.01

HBV

DNA

1

1

0.50

1

1

0.70

HBeAg

0.43

0.17–1.10

0.08

0.64

0.19–2.15

0.47

Baseline

eGFR

0.98

0.96–1.00

0.03

0.98

0.95–1.00

0.04

Nephrotoxic agents

1.53

0.32–7.29

0.60

1.04

0.17–11.0

0.97